SGP · SpyGlass Pharma, Inc.
$26.51
+0.28 (+1.07%)
At close · Aug 21
Market Cap
$886.71M
Shares
33.45M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$26.51
Open$26.55
Day$26.27–27.44
Available close range$17.56–29.68
Avg vol 30d94K
Short int1.1M · 3.4% float · 12.1d
Short vol37%
Last earningsMay 26, 2026
DataFeb 2026–Aug 2026
Filing10-Q · Aug 6
The closing range uses available history since Feb 6, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+22%
above
RSI (14)
66
neutral
MACD trend
Positive
52-week position
74%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+29%
trailing
6-month return
−1%
trailing
Relative strength
−12%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+46% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.41% of float · ▲ +0.9% MoM · 12.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
51 holders — 13F breadth
Squeeze score
75
high risk · 0–100
Fundamentals
EPS growth
−10%
Y/Y
Free cash flow
$-33.5M
Balance sheet
$96.4M
net cash
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+22%
Bullish
RSI (14)
66
Neutral
MACD trend
Positive
Bullish
52-week position
74%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+46% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.41% of float · ▲ +0.9% MoM · 12.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
51 holders — 13F breadth
Price context
position in its available closing range
Range low $18
Now $27 · 74%
Range high $30
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SGP
this stock
SpyGlass Pharma, Inc.
|
$886.71M | — | — | — | 3.4% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$58.31B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SGP | +1.2% | +29.4% | -0.8% | +17.7% | — |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +2.6% | +25.8% | -12.4% | +15.2% | — |
Key facts
CIK
1778922
CUSIP
85220G109
13F (30d)
50 filings
50 filers
Visit website
Investor relations